Mott retires from NEA
Dave Mott, the former Smith Barney investment banker, CEO of MedImmune and longtime VC, has announced his retirement from New Enterprise
Gathering data...
Dave Mott, the former Smith Barney investment banker, CEO of MedImmune and longtime VC, has announced his retirement from New Enterprise